Prenatal in utero conditions are thought to play a role in the development of adult diseases including Parkinson's disease (PD). Paraquat is a common herbicide with chemical structure similar to 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine, a neurotoxin known to induce parkinsonism. In order to assess the role of in utero paraquat exposure in PD, uptake in maternal and fetal brains were measured using positron emission tomography (PET)/computed tomography (CT) imaging. Two anesthetized pregnant rhesus macaques in the late second trimester of pregnancy were given bolus iv injections of 11 C-paraquat, and whole-body PET/CT imaging was performed. Using maternal ventricular blood pool as the input function, the unidirectional influx rate constants (K i s), a measure of the irreversible transport of paraquat from plasma to brain, were calculated for the maternal and fetal brains using Patlak graphical analysis. Results indicate minimal uptake of paraquat by both maternal and fetal brains with average K i s of 0.0009 and 0.0016 per minute, respectively. The highest regional cerebral uptake in the maternal brain (0.0009% injected dose) was seen in the pineal gland, a structure known to lack a blood brain barrier. The finding of minimal paraquat uptake in maternal and fetal brains is similar to previous findings in adult male macaques and extends the contention that a single acute paraquat exposure, prenatally or postnatally, is unlikely to play a role in PD.
In utero conditions during development of the vulnerable fetus are thought to play a role in adult disease (Barker 2007) . The theory of developmental origins of disease evolved from epidemiological findings showing that in utero undernutrition, for example, can lead to higher risk for developing coronary heart disease, type 2 diabetes, and hypertension in adulthood (Barker et al., 2002) . Similarly, other in utero conditions in rhesus macaques such as exposure to prenatal alcohol and stress have also been observed to lead to behavioral and neurochemical effects in adulthood (Schneider et al., 2008) .
Parkinson's disease (PD) is a neurodegenerative adult disease thought to have environmental factors influencing the risk of those with genetic susceptibilities . The notion that exposure to environmental neurotoxins has causative role in PD gained support from the discovery that acute intoxication with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), an analog of the synthetic opioid meperidine, destroyed central nervous system (CNS) dopamine cells and caused irreversible parkinsonism in exposed individuals (Langston et al., 1983) . Prenatal MPTP exposure of mice (Fredriksson et al., 1993) and nonhuman primates (Pérez-Otaño et al., 1992) similarly led to profound damage to the fetal CNS dopamine system consistent with PD, supporting the fetal developmental basis of some PD (Barlow et al., 2007) .
Soon after the finding that MPTP intoxication led to parkinsonism, the search for environmental agents with chemical structures similar to MPTP identified paraquat, a common herbicide, as a possible PD neurotoxin (Barbeau et al., 1985) . Indeed paraquat has been demonstrated to be a potent toxin to dopamine cells in vitro (McCormack et al., 2005) and molecular mechanisms underlying paraquat neurotoxicity continue to be elucidated (e.g., Ortiz-Ortiz et al., 2010) . Although in vitro studies have clearly shown the toxicity of paraquat to dopamine cells, in vivo results have not been as convincing, primarily because of questions regarding the ability of paraquat to cross the blood brain barrier (Koller, 1986; Miller, 2007) .
We previously reported that paraquat is minimally taken up in the adult male rhesus monkey brain in vivo (Bartlett et al., 2009) . To reach toxic levels in the adult primate brain in an acute exposure, lethal paraquat levels in peripheral organs, especially the lungs and kidneys, are likely to be reached first. To explore the possible role of in utero exposure to paraquat as a risk factor in PD, the ability of paraquat to enter fetal brains after acute IV administration of 11 C-paraquat to pregnant rhesus macaques was assessed in vivo using positron emission tomography (PET)/CT imaging.
MATERIALS AND METHODS
Chemicals and radiochemicals. The preparation of 11 C-paraquat was described previously (Bartlett et al., 2009) . Briefly, paraquat dichloride and 4, 4#-bipyridine (dipyridyl) were purchased from Sigma-Aldrich Chemical Inc.
(St Louis, MO). The precursor to prepare [ 11 C-methyl]-paraquat, desmethylparaquat (1-methyl-4, 4#-bipyridine), was prepared by monomethylating 4,4#-bipyridine (dipyridyl) using methyl iodide and the resulting quaternary ammonium iodide salt of 1-methyl-4, 4#-bipyridine was then converted to the corresponding quaternary ammonium triflate salt. [ 11 C-methyl]-paraquat was prepared via the reaction of 11 C-methyl triflate with the 1-methyl-4, 4#-bipyridine ammonium triflate salt using a published method (Jewett and Kilbourn, 2002) . Reverse-phase high-performance liquid chromatographic (HPLC) purification of the product was carried out on HPLC system consisting of an Econosphere (10 3 250 mm) 10-micron silica semipreparative column (Alltech Associates, Deerfield, IL), a Gilson 302 HPLC pump (5 ml/min 65:35 mixture of acetonitrile and 0.8% NaCl aqueous solution, pH 2.0), a Gilson 116 UV detector set at 257 nm (Gilson Inc., Middleton, WI), and a single channel NaI(Tl) radioactivity detector. The fraction containing the 11 C-paraquat peak was collected, evaporated to near dryness, reconstituted in sterile saline, and then sterilized through a 0.22-micron filter prior to injection to the rhesus macaques. Specific activities ranged from 210 to 1500 Ci/mmol.
Rhesus monkey subjects. Two healthy pregnant rhesus monkeys (described in Table 1 ) were selected from the Wisconsin National Primate Research Center breeding colony based on gestational age of the fetus and the health and breeding history of the pregnant animal. These studies were performed under an approved Institutional Animal Care and Use Committee (IACUC) protocol in accordance with Public Health Service (PHS) policy for animal care and use as described in the Guide for the Care and Use of Laboratory animals.
Based on the rhesus gestation period of 165 days, both subjects were in the late second trimester of pregnancy when these studies were performed. This choice in gestational age was a compromise between fetal brain size compatible with the resolution of the PET/CT scanner and stage of fetal rhesus brain growth (Benveniste et al., 2006) . It should be noted that fetal rhesus brain development by day 135 is comparable to that of a human newborn (NewellMorris and Fahrenbruch, 1985) . Thus, the developmental ages of the rhesus fetal brains in this study is similar to that of a human fetal brain in the third trimester.
PET/CT imaging. Animals were scanned on a GE Discovery LS PET/CT scanner, with a 5-mm full-width half-maximum (FWHM) resolution at the center of the field of view (FOV) and approximately an 8-mm FWHM at the edge of the 55-cm FOV. Animals were oriented perpendicularly to the length of the scanner bed in a left lateral decubitus position. This unconventional orientation enabled dynamic imaging of the fetus and all maternal internal organs including the heart, in a single-bed position. Data were acquired in 2D mode to maximize image resolution and reduce scatter. A dynamic imaging sequence of eight 15-s frames, six 30-s frames, three 1-min frames, one 2-min frame, four 5-min frames, and six 10-min frames for a total of 90 min scan duration was initiated simultaneously with the injection of 11 C-paraquat via a saphenous vein. The short frame durations early in the study allowed modeling the rapidly changing tracer kinetics in cerebral regions and allowed the identification of the left ventricular chamber of the maternal heart, from which the blood activity concentration could be obtained for the entire study. CT data were acquired at 120 kV and 30 mA prior to PET image acquisition to verify positioning and for later use in transmission attenuation correction of the PET emission data.
The raw PET data were normalized and corrected for deadtime, randoms, scatter, and attenuation. Using the scanner's proprietary software, the images were reconstructed using an iterative ordered subsets expectation maximization algorithm (2 iterations, 28 subsets) into a 256 3 256 (transverse) 3 35 (axial) image matrix with 1.95 3 1.95 3 4.25 mm pixel size. The CT data were reconstructed into a 512 3 512 3 35 image matrix with a 0.98 3 0.98 3 4.25-mm pixel size. Image analysis was performed using the software package Amira 4.1. The skulls of both mother and fetus visible in the CT image were used to delineate maternal and fetal brain regions of interest (ROIs) to generate time-activity curves (TACs) from the dynamic PET data set. Both maternal and fetal brain TACs were then normalized for injected dose (ID) and body weight.
Peripheral and cerebral plasma time course of paraquat. Blood samples were not taken in this study to minimize the invasiveness of this imaging procedure on the fragile pregnant animals. Previously reported adult male monkey blood kinetic data (Bartlett et al., 2009 ) based on blood samples collected in four animals were reanalyzed to obtain whole-blood and plasma kinetic data which was then applied to the PET-derived left ventricular heart image kinetic data to generate the female plasma curve. Male and extrapolated female plasma curves were normalized for ID and body weight and then plotted against time to obtain 11 C-paraquat TACs. To estimate cerebral blood plasma 11 C-paraquat TACs, the measured plasma TACs were scaled by the fractional cerebral blood volume (CBV) in rhesus monkeys of 5 ml/100 g (Eichling et al., 1975) .
Maternal and fetal uptake rate constant, K i . The irreversible influx rate constant (K i ), a measure of the rate of tracer accumulation in tissue in relation to the amount of tracer available in plasma at equilibrium (Patlak et al., 1983) , was evaluated over the whole maternal and fetal brains. K i is obtained as the slope of the linear portion of the plot of tissue and blood tracer concentration against time normalized to reflect the changing plasma tracer concentration. The maternal plasma curve was used as the plasma concentration for both the mother and fetus. The use of the maternal plasma curve in the analysis of fetal brain data has previously been demonstrated (Bartlett et al., 2010b) . Considering the fetus as a maternal organ, any exogenous compound introduced into the fetal circulation derives from the maternal arterial blood supply. Thus, if each step in the sequence of events involved in delivery of tracer from maternal arterial blood to the irreversible accumulation in fetal brain is reversible and capable of reaching equilibrium, the assumptions required by the graphical approach are met and meaningful K i s can be estimated (Bartlett et al., 2010b) .
RESULTS
The mean of plasma time-activity curves for paraquat obtained in four male macaques in the previous report (Bartlett et al., 2009 ) was fitted to a biexponential linear least squares function of time and shown in Figure 1A . The fitted plasma curve was scaled to CBV (5%) to obtain the cerebral plasma curve presented in Figure 1B together with the plot of the average of the normalized whole-brain PET TACs obtained in the four male monkeys.
The whole-body sagittal CT, PET (averaged over the last 60 min of image data), and the co-registered PET/CT images of one pregnant subject are shown in Figure 2A . Figure 2B shows early (0-2 min), mid (20-30 min), and late (50-90 min) times of 11 C-paraquat localization in the maternal whole brain (top) and fetal whole brain (bottom). The dual discs of the placenta are clearly seen in the early PET image (Fig. 2B ) and the ability of paraquat to enter the fetus via the placenta can be observed at later times. Some recognizable maternal organs based on both PET and CT are identified in Figure 2A . ROIs representing maternal brain and fetal brain, easily delineated using the fetal skull seen in the CT image and fused PET/CT image ( Fig. 2A) and identifiable as the dark circular area in the bottom PET images (Fig. 2B) , allowed Patlak graphical analysis of the whole-brain time activity curves for both mother and fetus. Using the last 30 min of the PET data, average maternal and fetal K i s of 0.0009 and 0.0016 per minute, respectively, were obtained. The highest cerebral uptake in the maternal brain was seen in the pineal gland (0.0009% ID), a structure known to lack a blood brain barrier. Similar to previously reported male data (Bartlett et al., 2009) , the maternal brain structures with nonzero K i s, indicating clearance slower than blood clearance, were structures comprising the blood cerebrospinal fluid barrier such as the lateral ventricles (data not shown).
The maternal whole-brain TAC data plotted with the scaled female cerebral plasma TAC is shown in Figure 3A . Figure 3B shows the maternal and fetal whole-brain TACs to be essentially indistinguishable after about 10 min and beyond.
DISCUSSION
The plethora of man-made chemicals in the environment has made assessment of risks posed by exposure to these chemicals a vital public health concern. Because of the vulnerability of the fetus, in utero exposure is a critical factor to consider in evaluating the toxicology of environmental chemicals. One important aspect of rational risk assessment is quantitation of exposure. Although physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling (Zhang et al., 2007) are useful in risk assessment, actual measurement of the pharmacokinetics of putative toxins is needed not only to obtain real-world exposure data but also to validate and refine PBPK/PD models.
PET is a noninvasive imaging technique that can provide quantitative pharmacokinetic data of microdoses of environmental chemicals. PET imaging is particularly useful in imaging pregnant nonhuman primates to assess in vivo pharmacokinetics of chemicals of interest in the fetus in utero. PET imaging was first used in the study of maternal-fetal exchange and fetal biodistribution in monkeys by Lindberg et al. (1985) . Other PET studies have reported the maternal-fetal transfers of opioids (Hartvig et al., 1989) , amino acids (Berglund et al., 1990) , and cocaine (Benveniste et al., 2005 (Benveniste et al., , 2010 . PET/CT imaging of pregnant monkeys as a tool to quantitatively assess fetal uptake of environmental chemicals to provide a basis for establishing the role of in utero fetal exposure in adult disease has also been described (DeJesus et al., 2006) .
As seen in Figure 1B , paraquat clearance rates in the whole brain and cerebral plasma of the male monkeys were similar, but a slight excess of radioactivity is seen in the whole brain at later times. This slight excess is attributed to the transfer and longer retention of 11 C-paraquat in the pineal gland and the lateral ventricles, both of which lack a blood-brain barrier (BBB), as contrasted to structures within the BBB including the dopaminergic caudate-putamen areas (Bartlett et al., 2009) .
Whole-body localization of paraquat in the pregnant female macaques ( Fig. 2A) shows the accumulated levels of paraquat in the last 40 min of the study. The combination of PET and CT allowed identification of some maternal organs such as the brain, lungs, liver, kidney, bladder, placenta, and the fetus (Fig. 2A) . The early time (0-2 min) image in Figure 2B shows paraquat localization is high in well-perfused maternal areas-nasal area, salivary glands, and placenta.
The similarity of the overall behavior between brain and plasma in the female data (Fig. 3A) to that in the male data (Fig. 1B) support the use of the male blood data to estimate the female plasma curve in order to reduce the stress of this procedure on the fragile pregnant macaque. Figure 3B shows the mean maternal and fetal whole brain data to be nearly indistinguishable. Partial volume effects on the fetal brain data were assessed but were found not to significantly alter the calculated fetal brain TACs.
The average maternal and fetal cerebral paraquat K i s of 0.0009 and 0.0016 per minute, respectively, were not statistically different. These K i s are about 10-to 20-fold less than that for the brain penetrating glucose analog, fluorodeoxyglucose, reported to be 0.0189 per minute (Benveniste et al., 2010) .
Although it was not possible to delineate fetal brain substructures from the CT image, the apparent overall similarity in behavior demonstrated in Figure 3B suggests that paraquat accumulation in the fetal brain can be extrapolated from adult male and female macaques. The tight junctions (passive permeability barrier or mechanism that excludes macromolecules from the adult brain) of the blood brain barrier are known to be present from the earliest stages of brain development, whereas the interface between the blood and CSF of the choroid plexus has greater passive permeability (Liddelow et al., 2009) . Pericyte-regulated expression of tight-junction molecules and the BBB-specific marker glucose transporter 1 (Glut1) by endothelial cells were found in the mouse cerebral cortex as early as embryonic day 11 and day 12 for the rat (Daneman et al., 2010) . The low-molecular mass tracer biotin, which is excluded from the CNS parenchyma by the BBB in postnatal animals, was also excluded from fetal brain as early as embryonic day 15 (Daneman et al., 2010) .
There are several limitations to this study. First is the small number of subjects (n ¼ 2) involved in this study. However, the similarity of the fetal brain TACs with those for six adult brains-four males from a previous study (Bartlett et al., 2009) and two females in this study-supports the validity of these findings under these experimental conditions. Another limitation is the single gestation period investigated. Also, only one route of administration (IV) was studied, whereas more probable routes of exposure-for example, inhalation, oral ingestion, or transdermal absorption, are known to have different time courses (Chui et al., 1988) . Another is the tracer or microdose used in this study, which did not lead to pharmacological effects observed in previous monkey studies (Purser and Rose, 1979) wherein renal failure led to altered paraquat excretion and finally death. Furthermore, this acute study does not inform on the role of chronic exposure whose cumulative effects have been linked to PD (Tanner et al., 2011) . Coexposure with other chemicals such as maneb, suggested by epidemiological studies as a significant risk factor in PD (Costello et al., 2009) , may also lead to paraquat biodistribution different from the present findings.
In summary, results of this study found minimal paraquat uptake in maternal and fetal brains, similar to previous findings in adult male macaques (Bartlett et al., 2009) . These findings extend the contention that acute paraquat exposure either in utero or postnatally is unlikely to play a role in PD. Other paraquat exposure conditions, for example, chronic exposure, coexposure with other agents, etc., were not addressed in this study. Future PET studies should assess paraquat uptake in adult and fetal brains before and after reality-based exposure paradigms.
In addition to toxicology of environmental chemicals and drugs of abuse, other applications wherein PET/CT imaging of pregnant nonhuman primates can provide quantitative information include (1) evaluation of current and new drugs wherein the therapeutic target is either the mother or the fetus, (2) fetal radiation dosimetry of agents used in nuclear medicine (Bartlett et al., 2010a) , and (3) fetal development of neuroreceptors, such as dopamine D2 receptors (Bartlett et al., 2010b) and other proteins, using appropriate positron-labeled markers. 
